Newsroom

Industry News

11 Sep

NXT-ID Commences Trading on NASDAQ Capital Market

Nxt-ID, Inc. (NASDAQ: NXTD), a biometric authentication company focused on the growing mobile commerce market, announced today that its shares of common stock and warrants to purchase common stock have commenced trading on The Nasdaq Capital Market. The common stock and warrants and will trade under the symbols “NXTD” and...

Read more

10 Sep

Oragenics Appoints Key Hires to Drive Lantibiotic Platform Growth and Expansion

Transformative Lantibiotic Platform to Treat Various Life-Threatening Infectious Diseases Oragenics, Inc. (OGEN), a leader in the development of novel, effective antibiotics and oral care probiotics, today announced two new appointments to the Product Development team. Joining the company are Guojun (Shawn) Nie Ph.D., as Director of Process Development, and...

Read more

10 Sep

Nxt-ID, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

Nxt-ID, Inc. (Nasdaq:NXTD and NXTDW) (“Nxt-ID” or the “Company”), a biometric authentication company focused on the growing mobile commerce market, today announced the pricing of an underwritten public offering of 2,127,273 of shares of common stock and warrants to purchase 2,127,273 shares of common stock at a combined public...

Read more

10 Sep

Cesca Therapeutics to Present at Aegis Healthcare & Technology Conference

Cesca Therapeutics Inc. (KOOL), an autologous cell-based regenerative medicine company, announced today it will present at the Aegis Healthcare & Technology Conference on Friday, September 12, 2014 at the Encore at the Wynn Las Vegas. The Company’s presentation by Matthew Plavan, the Company’s Chief Executive Officer is scheduled to...

Read more

10 Sep

MD Anderson Department Chair Richard E. Champlin, M.D. Joins Actinium’s Iomab™-B Scientific Advisory Board

Currently Leading the Largest Bone Marrow Transplant Program in the World, Dr. Champlin Will Provide Guidance for the Upcoming Pivotal Trial of Iomab™-B Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced the...

Read more

9 Sep

Soligenix (SNGX) Announces Issuance of US Patent for ThermoVax™ Technology

New patent includes composition of matter claims Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the US Patent and Trademark Office (US PTO) granted patent 8,808,710 entitled “Method...

Read more

9 Sep

Calpian’s Money-On-Mobile Surpasses 100 Million Cumulative Unique Users, Continues Rapid Growth as India’s Leading Mobile Payments Provider

Money-On-Mobile sustains strong month-over-month growth, expands retail distribution network to 210,497 locations across India, increases monthly processed volume 62 percent over six months Calpian, Inc. (OTCQB: CLPI) announced that for the month ending August 31, 2014, its Mumbai-based subsidiary Money-On-Mobile has been accessed by more than 103 million cumulative...

Read more

Page 259 of 274« First...102030...257258259260261...270...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address